Rare Diseases & Orphan drugs

Rare diseases are life-threatening or chronically debilitating conditions, affecting no more than 5 in 10,000 persons in the European Community according to the Regulation (EC) N. 141/2000 of the European Parliament and of the Council. It is estimated that between 6000 to 8000 distinct rare diseases affect up to 6% of the total EU population. Therefore, these conditions can be considered rare if taken individually but they affect a significant proportion of the European population when considered as a single group. Several initiatives have been taken at international, European and national level to tackle public health as well as research issues related to diagnosis, prevention, treatment and surveillance of these diseases. An Orphan drug can be defined as the one that is used to treat an orphan disease. An orphan disease in USA is defined as the one that affects fewer than 200000 individuals, but in Japan the number is 50,000 and in Australia is 2000. In past 20 years efforts have been made to encourage companies to develop orphan drugs. The Orphan Drug Act in the USA (1983) was succeeded by similar legislation in Japan (1985), Australia (1997), and the European Community (2000). The encouragement takes three forms: tax credits and research aids, simplification of marketing authorization procedures, and extended market exclusively. 

  • Craniofacial Morphogenesis
  • Diverse Immunotherapy Approaches
  • T cell immunotherapy
  • Gene, stem cell and future therapies for orphan diseases
  • Rare Diseases and Regenerative Medicine

Related Conference of Rare Diseases & Orphan drugs

Feb 28- March 2, 2019

22nd Global Congress on Biotechnology

Berlin, Germany
March 11-12, 2019

12th World Congress on Cell & Tissue Science

| Holiday Inn Singapore Atrium, Singapore
March 25-26, 2019 |

11th World Congress and Expo on Cell & Stem Cell Research

Orlando, Florida, USA
April 15-16, 2019

7th International Conference on Integrative Biology

Berlin, Germany
April 24-25, 2019

13th International Conference on Bio Banking and Tissue Preservation

Vancouver, British Columbia, Canada
May 01-02, 2019

7th Asia Pacific Plant Biology and Plant Science Congress

| Courtyard by Marriott Seoul Times Square | Seoul, South Korea
May 01-02, 2019,

25th Asia Pacific
Biotechnology Congress

ANA Crowne Plaza Kyoto, Japan
May 13-14, 2019

6th World Congress on Synthetic Biology and Advanced Biomaterials

| Mercure Albert Park | Melbourne, Australia
June 10-11, 2019

International Conference on Cell Biology and Genomics

Helsinki, Finland
July 31-Aug 01, 2019

2nd Annual Biotechnology Congress

Chicago, USA
August 22-23, 2019

5th International Congress on Epigenetics & Chromatin

Vienna, Austria
August 22-23, 2019

5th International Congress on Epigenetics & Chromatin

Vienna, Austria
September 9-10, 2019

23rd European Biotechnology Congress

Zurich, Switzerland
September 23-24, 2019

10th International Conference on Tissue Science and Regenerative Medicine

| Radisson, Narita | Tokyo, Japan
October 18-19, 2019

25th Biotechnology Congress: Research & Innovations

Dallas, USA
November 22-23, 2019

6th World Congress on Epigenetics and Chromosome

Dubai, UAE

Rare Diseases & Orphan drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in